Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Revlimid

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Revlimid was produced by Celgene.

Merck suspends two Keytruda trials after patient deaths

Merck suspends two Keytruda trials after patient deaths Investigators to look at Keytruda with Pomalyst and Revlimid. Merck &Co has paused patient enrolment in two trials of Keytruda to allow investigators to explore reports of deaths among patients taking ... The two trials - KEYNOTE-183 and KEYNOTE-185 -

J&J gets CHMP backing for broader Darzalex use

J&J gets CHMP backing for broader Darzalex use Celgene's Revlimid (lenalidomide) plus dexamethasone and Takeda's Velcade (bortezomib) plus dexamethasone - have already been tried.

Celgene pays $300m upfront for immunology start-up Delinia

Celgene pays $300m upfront for immunology start-up Delinia Star oncology drug Revlimid (lenalidomide) for blood cancer grew 16% to $1.81bn in the quarter, with follow-up Pomalyst/Innovid (pomalidomide) up 29% to $378m.

Celgene bid to push Revlimid beyond myeloma blocked again

Celgene bid to push Revlimid beyond myeloma blocked again the lymphoma market - which it has previously said could add another $1bn-$1.5bn to Revlimid’s peak sales. ... Revlimid has been a cash cow for Celgene for years and is on course to bring in around $8bn this year.

Takeda gets EU green light for oral myeloma drug

Takeda gets EU green light for oral myeloma drug drug Revlimid (lenalidomide) and dexamethasone in patients with myeloma who have been treated with at least one prior therapy.

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics